CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
批准号:
6375614
负责人:
MARK E SMULSON
金额:
$24.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-06-01 至 2003-07-31
关键词:
ADP ribosylation DNA directed DNA polymerase DNA repair DNA replication adenosine diphosphate apoptosis carcinogen testing chemical carcinogen chemical carcinogenesis chemical structure function chromatin enzyme activity genetic recombination genetically modified animals laboratory mouse mutagen testing nucleic acid structure p53 gene /protein pentosyltransferase pulsed field gel electrophoresis transcription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Poly(ADP-ribose) polymerase (PARP) is activated by binding to DNA
strand breaks and contributes to various nuclear processes involving DNA strand
breaks. This amended proposal aims to characterize the precise roles of PARP in
DNA replication-repair and in apoptosis. It is based on the overall hypothesis
that the covalent attachment of long, negatively charged chains of
poly(ADP-ribose) (PAR) renders target DNA-binding proteins "DNA-phobic" and
that removal of PAR would then restore the affinity of these proteins for
binding sites on DNA.
Specific Aim 1A focuses on the role of PARP as a component of the multiprotein
replication complex (MRC), or "synthesome", which comprises about 40 proteins
and is able to replicate, faithfully, SV40 DNA. MRCs derived from several
cancer cell are error-prone. Several MRC components undergo
poly(ADP-ribosyl)ation [p(ADP-R)n]; the use of cells from PARP knockout mice
will be used to determine the function(s) of p(ADP-R)n on MRC proteins during
DNA replication. To this end, the applicant will initially focus on one major
facet--whether the MRC, purified from PARP knockout cells versus controls,
exhibits a defect similar to cancer cells, that of error-prone replication.
Specific Aim 1B focuses on E2F-1, which is normally induced during S phase of
the cell cycle, but is not so expressed in cells from PARP knockout mice. The
mechanism by which PARP regulates the promoter activity of this gene will
therefore be investigated. In addition, the applicant will examine the direct
interaction of PARP with the E2F-1 promoter directly, or in combination with
other signal proteins that act with E2F-1, as well as direct or indirect
effects of p(ADP-R)n on expression of E2F-1.
Specific Aim 2 is focused on the role of the early and transient p(ADP-R)n of
nuclear proteins, described during the last grant period, which occurs early
during apoptosis and is required for many of the subsequent changes
characteristic of programmed cell death. The temporal and spatial relations of
this transient p(ADP-R)n to changes in the structure of chromatin and the
nuclear matrix will be examined systematically and compared, in part, by using
PARP+/+ cells vs. PARP-/- cells to detect the function of p(ADP-R)n at this
early critical point of apoptosis.
The focus of Specific Aim 3 is the transcription factor and tumor suppressor
p53, one of the major targets of p(ADP-R)n during apoptosis. The applicant
identified p53 to be p(ADP-R)n briefly during the early burst of PAR in
apoptosis. The subsequent cleavage of PAR from p53 coincides temporally with
the activation of its target gene BAX. The mechanistic relation between this
reversible modification of p53 and its transactivation activity and function
will be determined in vitro and in the context of the whole cell by the use of
gel shift assays and the activity of other p53 responsive genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
-
批准号:2086109
-
项目类别:
-
资助金额:$17.59万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
-
批准号:3163723
-
项目类别:
-
资助金额:$16.65万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:6192920
-
项目类别:
-
资助金额:$24.31万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:2087361
-
项目类别:
-
资助金额:$18.68万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:2653960
-
项目类别:
-
资助金额:$19.96万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
-
批准号:3163724
-
项目类别:
-
资助金额:$17.29万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
-
批准号:3163721
-
项目类别:
-
资助金额:$13.28万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
-
批准号:3163718
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:3166825
-
项目类别:
-
资助金额:$14.81万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:2087359
-
项目类别:
-
资助金额:$19.58万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:3166822
-
项目类别:
-
资助金额:$14.66万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION (REVI
-
批准号:3163720
-
项目类别:
-
资助金额:$12.17万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
-
批准号:3163722
-
项目类别:
-
资助金额:$16.66万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:3166826
-
项目类别:
-
资助金额:$17.53万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:3166820
-
项目类别:
-
资助金额:$13.72万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:2330678
-
项目类别:
-
资助金额:$19.2万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:2871661
-
项目类别:
-
资助金额:$20.75万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:3166828
-
项目类别:
-
资助金额:$18.98万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
-
批准号:3166824
-
项目类别:
-
资助金额:$14.31万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
-
批准号:3163717
-
项目类别:
-
资助金额:$16.27万
-
财政年份:1979
-
负责人:MARK E SMULSON
-
依托单位: